Records containing: Light Chain Deposition Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-20Registry for Adults With Plasma Cell Disorders (PCD's)
-
CLINICAL_TRIALS study record update · 2025-04-20Pilot Study of Oral Rifaximin in Patients With Monoclonal Gammopathy
-
CLINICAL_TRIALS study record update · 2023-05-09Phase I Study of Pomalidomide, Bortezomib, and Dexamethasone (PVD) as First-Line Treatment of AL Amyloidosis or Light Chain Deposition Disease
-
CLINICAL_TRIALS study record update · 2022-05-11Single Autologous Transplant Followed by Consolidation and Maintenance for Participants ≥ 65 Years of Age Diagnosed With Multiple Myeloma or a Related Plasma Cell Malignancy
-
CLINICAL_TRIALS study record update · 2022-04-25A Prospective Cohort Study of Patients With Plasma Cell Disorders (PCDs) in PKUFH
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-05-18Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2021-05-18Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-04-15A Phase 1 Study of Reolysin Alone in Patients With Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-03-30A Multicenter Phase II Trial of Bortezomib (Velcade), Melphalan, and Dexamethasone (V-MD) in Patients With Symptomatic AL-Amyloidosis or Light Chain Deposition Disease
-
CLINICAL_TRIALS study record update · 2014-11-26A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients With Systemic Light-Chain (AL) Amyloidosis Ineligible for Autologous Stem-Cell Transplantation
-
CLINICAL_TRIALS study record update · 2014-03-17A Phase 1/Pharmacokinetic Study of Sunitinib in Patients With Cancer Who Also Have HIV and Are on HAART Therapy